Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
 
OverviewCollaboratingResearch FundingTrainingData Sharing
 

Research Funding Archive

Provocative Questions:

Group A generally relates to cancer prevention and risk.

Research Answers to NCI's Provocative Questions- Group A (R01)
RFA Number: RFA-CA-12-015
Application Receipt Date(s): June 20, 2013

Research Answers to NCI's Provocative Questions- Group A (R21)
RFA Number: RFA-CA-12-016
Application Receipt Date(s): June 20, 2013

Group B generally relates to mechanisms of tumor development or recurrence.

Research Answers to NCI's Provocative Questions- Group B (R01)
RFA Number: RFA-CA-12-017
Application Receipt Date(s): June 20, 2013

Research Answers to NCI's Provocative Questions- Group B (R21)
RFA Number: RFA-CA-12-018
Application Receipt Date(s): June 20, 2013

Group C generally relates to cancer detection, diagnosis, and prognosis.

Research Answers to NCI's Provocative Questions- Group C (R01)
RFA Number: RFA-CA-12-019
Application Receipt Date(s): June 20, 2013

Research Answers to NCI's Provocative Questions- Group C (R21)
RFA Number: RFA-CA-12-020
Application Receipt Date(s): June 20, 2013

Group D generally relates to cancer therapy and outcomes.

Research Answers to NCI's Provocative Questions- Group D (R01)
RFA Number: RFA-CA-12-021
Application Receipt Date(s): June 20, 2013

Research Answers to NCI's Provocative Questions- Group D (R21)
RFA Number: RFA-CA-12-022
Application Receipt Date(s): June 20, 2013

   

RFAs:

Validation and Advanced Development of Technologies for the Study of Biological Properties of Single Cells (R33)
RFA Number: RFA-RM-13-020
Application Receipt Date(s): April 04, 2014

Exceptionally Innovative Tools and Technologies for Single Cell Analysis (R21)
RFA Number: RFA-RM-13-021
Application Receipt Date(s): April 04, 2014

Revisions to Add Single Cell Analysis to Active Research Projects (R01)
RFA Number: RFA-RM-13-022
Application Receipt Date(s): April 04, 2014

Revisions to Add Single Cell Analysis to Active Research Projects (U01)
RFA Number: RFA-RM-13-023
Application Receipt Date(s): April 04, 2014

NIH Directors Biomedical Research Workforce Innovation Award: Broadening Experiences in Scientific Training (BEST) (DP7)
RFA Number: RFA-RM-13-019
Application Receipt Date(s): March 31, 2014

BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01)
RFA Number: RFA-NS-14-007
Application Receipt Date(s): March 24, 2014

BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01)
RFA Number: RFA-NS-14-008
Application Receipt Date(s): March 24, 2014

BRAIN Initiative: Integrated Approaches to Understanding Circuit Function in the Nervous System (U01)
RFA Number: RFA-NS-14-009
Application Receipt Date(s): March 24, 2014

BRAIN Initiative: Planning for Next Generation Human Brain Imaging (R24)
RFA Number: RFA-MH-14-217
Application Receipt Date(s): March 13, 2014

NIH National Research Mentoring Network (NRMN) (U54)
RFA Number: RFA-RM-13-017
Application Receipt Date(s): March 18, 2014

BRAIN Initiative: Transformative Approaches for Cell-Type Classification in the Brain (U01)
RFA Number: RFA-MH-14-215
Application Receipt Date(s): March 13, 2014

BRAIN Initiative: Development and Validation of Novel Tools to Analyze Cell-Specific and Circuit Specific Processes in the Brain (U01)
RFA Number: RFA-MH-14-216
Application Receipt Date(s): March 13, 2014

Development of a Microfluidic Platform for Blood Testing in Neonatal and Pediatric Patients STTR (R41)
RFA Number: RFA-HL-14-025
Application Receipt Date(s): February 10, 2014

Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01)
RFA Number: RFA-MH-14-214
Application Receipt Date(s): February 3, 2014

Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3)
RFA Number: RFA-CA-13-015
Application Receipt Date(s): January 6, 2014

Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21)
RFA Number: RFA-CA-13-001
Application Receipt Date(s): September 20, 2013

Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)
RFA Number: RFA-CA-13-002
Application Receipt Date(s): September 20, 2013

Early-Stage Development of Innovative Technologies for Biospecimen Science (R21)
RFA Number: RFA-CA-13-003
Application Receipt Date(s): September 20, 2013

Validation and Advanced Development of Emerging Technologies for Biospecimen Science (R33)
RFA Number: RFA-CA-13-004
Application Receipt Date(s): September 20, 2013

Preclinical Innovation Program (PIP) (R01)
RFA Number: RFA-AI-13-008
Application Receipt Date(s): August 1, 2013

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44)
RFA Number: RFA-CA-12-023
Application Receipt Date(s): March 6, 2013

NIH Director's Early Independence Awards (DP5)
RFA Number: RFA-RM-12-018
Application Receipt Date(s): January 30, 2013

Clinical Utility of Extracellular RNA for Biomarker Development (UH2/UH3)
RFA Number: RFA-RM-12-013
Application Receipt Date(s): November 13, 2012

Extracellular RNA Biogenesis, Biodistribution, Uptake, and Effector Function (U19)
RFA Number: RFA-RM-12-012
Application Receipt Date(s): November 13, 2012

Reference Profiles of Human Extracellular RNA (U01)
RFA Number: RFA-RM-12-011
Application Receipt Date(s): November 13, 2012

Clinical Utility of Extracellular RNA for Therapy Development (UH2/UH3)
RFA Number: RFA-RM-12-014
Application Receipt Date(s): November 13, 2012

NIH Director's Transformative Research Awards (R01)
RFA Number: RFA-RM-12-017
Application Receipt Date(s): September 21, 2012

Early-Stage Innovative Technology Development for Cancer Research (R21)
RFA Number: RFA-CA-12-002
Application Receipt Date(s): September 18, 2012

Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
RFA Number: RFA-CA-12-003
Application Receipt Date(s): September 18, 2012

Innovative and Early-Stage Development of Emerging Technologies in Biospecimen Science (R21)
RFA Number: RFA-CA-12-004
Application Receipt Date(s): September 18, 2012

Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33)
RFA Number: RFA-CA-12-005
Application Receipt Date(s): September 18, 2012

U.S.-China Program for Biomedical Collaborative Research (R01)
RFA Number: RFA-AI-12-021
Application Receipt Date(s): September 18, 2012

Research Answers to NCI's Provocative Questions (R21)
RFA Number: RFA-CA-11-012

Research Answers to NCI's Provocative Questions (R01)
RFA Number: RFA-CA-11-011

2012 NIH Director's New Innovator Award Program (DP2)
RFA Number: RFA-RM-11-005

Application and Use of Transformative Emerging Technologies in Cancer Research
RFA Number: RFA-CA-10-003

Application and Use of Transformative Emerging Technologies in Cancer Research
RFA Number: RFA-CA-10-004

Innovative Technology Development for Cancer Research
RFA Number: RFA-CA-10-005

Technologies for Image-Guided Interventions (R01)
RFA Number: RFA-EB-09-002
Pre-Application Meeting: January 20, 2010

Innvovation in Molecular Imaging Probes (R01)
RFA Number: RFA-RM-09-022
Pre-Application Meeting: January 21, 2010

Centers of Cancer Nanotechnology Excellence
RFA Number: RFA-CA-09-012
Pre-Application Meeting: July 23, 2009
Letters of Intent Receipt Date: September 14, 2009
Application Receipt Date(s): October 14, 2009
View CCNE pre-application meeting details

Cancer Nanotechnology Platform Partnerships
RFA Number: RFA-CA-09-013
Pre-Application Meeting: July 23, 2009
Letters of Intent Receipt Date: September 14, 2009
Application Receipt Date(s): October 14, 2009
View Platform Partnership pre-application meeting details

The Early Detection Research Network: Biomarker Developmental Laboratories
RFA Number: RFA-CA-09-017
Application Receipt Date(s): October 29, 2009

   

Proposal Solicitations:

FY13 Solicitation of Applications to the Bridging Interventional Development Gaps (BrIDGs) Program
RFA Number: NOT-RM-13-003
Application Receipt Date(s): February 1, 2013

Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2013-1)
Notice Number: NOT-OD-12-137
Application Receipt Date(s): November 13, 2012
Note- numerous relevant funding opportunities are included.

NCI Experimental Therapeutics (NExT) Program
Application Receipt Date(s): October 15, 2012
Visit website

Reformulation of Cancer Therapeutics Using Nanotechnology (SBIR)
Contract Proposal Receipt Date: November 7, 2011 by 5:00 PM. EST

Probing Tumor Microenvironment Using In-vivo Nanotechnology-based Sensors (SBIR)
Contract Proposal Receipt Date: November 7, 2011 by 5:00 PM. EST

Creative and Novel Ideas in HIV Research (CNIHR)
Concept Proposal Receipt Date: October 17, 2011

siRNA Studies for Nanotherapeutics
Solicitation Number: S11-039
Application Receipt Date(s): January 25, 2011

Therapeutics and Theranostics Based on Nanotechnology
Contract Number: PHS 2011-1/300
Application Receipt Date(s): November 8, 2010

Nanotechnology Sensing Platforms for Improved Diagnosis of Cancer
Contract Number: PHS 2011-1/301
Application Receipt Date(s): November 8, 2010

Highly Potent Cancer Nanotherapeutics
Solicitation Number: S10-140
Response Date: April 28, 2010

NCI Nanotechnology Characterization Laboratory Solicitation of Nanotechnology Strategies for Cancer Research
Notice Number: NOT-CA-05-011
Application Receipt Date(s): March 1, 2010
View website

Highly Potent Cancer Therapeutics Using Nanotechnology
Solicitation Number: S10-038
Response Date: October 30, 2009

NIH SBIR Contract Solicitation
Nanotechnology Topics:

Application Receipt Date(s): November 8, 2009
Visit website

   

PAs:

Additional Research Training Positions for NIAAA–, NIDA–, or NCI–Supported NRSA Institutional Training (T32) Grants (Admin Supp)
Program Announcement Number: PA-14-146
Application Receipt Date(s): April 9, 2014

Shared Instrumentation Grant Program (S10)
Announcement Number: PA-14-073
Application Receipt Date(s): March 21, 2014

Administrative Supplements for Research on Sex/Gender Differences (Admin Supp)
Announcement Number: PA-14-027
Application Receipt Date(s): February 6, 2014

NIH Pathway to Independence Award (Parent K99/R00)
Program Announcement Number: PA-14-042
Application Receipt Date(s): View schedule

Mentored Quantitative Research Development Award (Parent K25)
Program Announcement Number: PA-14-048
Application Receipt Date(s): View schedule

NIBIB Biomedical Technology Resource Centers (P41)
Program Announcement Number: PAR-13-144
Application Receipt Date(s): View schedule

PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications
Program Announcement Number: PA-13-088
Application Receipt Date(s): View schedule

Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50)
Program Announcement Number: PAR-12-296
Application Receipt Date(s): May 20, 2014; September 23, 2014

Image Guided Drug Delivery in Cancer (R01)
Program Announcement Number: PA-09-253
Application Receipt Date(s): View schedule

Image-Guided Cancer Interventions (SBIR R43/R44)
Program Announcement Number: PAR-10-079
Application Receipt Date(s): View schedule

Image-Guided Cancer Interventions (STTR R41/R42)
Program Announcement Number: PAR-10-080
Application Receipt Date(s): View schedule

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research
Program Announcement Number: PAR-09-162
Application Receipt Date(s): View schedule

Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership
Program Announcement Number: PAR-09-201
Application Receipt Date(s): View schedule

PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications
Program Announcement Number: PA-13-089
Application Receipt Date(s): View schedule

Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]
Program Announcement Number: PA-09-187
Application Receipt Date(s): View schedule

Technologies and Software to Support Integrative Cancer Biology Research (SBIR) [R43/R44]
Program Announcement Number: PA-09-188
Application Receipt Date(s): View schedule

Technology for the Detection and Characterization of Low Abundance Proteins, Peptides, or micro RNAs (SBIR) [R43/R44]
Program Announcement Number: PA-09-189
Application Receipt Date(s): View schedule

Biomechanics and Mechanobiology
Program Announcement Number: PD 08-7479
Application Receipt Date(s): October 1, 2013

Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology [SBIR (U43/U44)]
Program Announcement Number: PAR-10-286
Application Receipt Date(s): July 8, 2013

PHS 2010-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications
Program Announcement Number: PA-10-051
Application Receipt Date(s): View schedule

Integrative, Hybrid & Complex Systems
Program Announcement Number: PD 10-7564
Application Receipt Date(s): October 7, 2012

Exploratory/Developmental Bioengineering Research Grants (EBRG) [R21]
Program Announcement Number: PA-10-010
Application Receipt Date(s): View schedule

A Pre-application for the NIH-Industry Pilot Program: Discovering New Therapeutic Uses for Existing Molecules (X02)
RFA Number: PAR-12-203
Application Receipt Date(s): August 14, 2012

Macromolecular, Supramolecular and Nanochemistry
Program Announcement Number: PD 09-6885
Application Receipt Date(s): July 31, 2012

Resource Access for the Bridging Interventional Development Gaps Program (X01)
Program Announcement Number: PAR-12-092

Quick Trials for Imaging and Image-Guided Interventions: Exploratory Grants (R21)
Program Announcement Number: PAR-08-147

Nanoscience and Nanotechnology in Biology and Medicine
Program Announcement Number: PA-08-052
Application Receipt Date(s): View schedule

Nanoscience and Nanotechnology in Biology and Medicine
Program Announcement Number: PA-08-053
Application Receipt Date(s): View schedule

Clinical Cancer Therapy and Prevention Research (R01)
Program Announcement Number: PA-07-356
Application Receipt Date(s): View schedule

PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications
Program Announcement Number: PA-10-050
Application Receipt Date(s): August 5; December 5, 2010

Bioengineering Research Partnerships (BRP)
Program Announcement Number: PAR-07-352
Application Receipt Date(s): View schedule

Quick Trials for Novel Cancer Therapies and Prevention: Exploratory Grants (R21)
Program Announcement Number: PAR-08-025
Application Receipt Date(s): July 9; November 9, 2010

FY10 Peer Reviewed Cancer Research Program (PRCRP)
Application Receipt Date(s): July 14, 2010

Image-Guided Cancer Interventions
Program Announcement Number: PA-07-041
Application Receipt Date(s): View schedule

Image-Guided Cancer Interventions
Program Announcement Number: PA-07-042
Application Receipt Date(s): View schedule